Home | ICH Structure | ICH Steering Committee | ICH Process | ICH Topics | ICH Meetings | ICH News |
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is a unique project that brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry in the three regions to discuss scientific and technical aspects of product registration.
The purpose is to make recommendations on ways to achieve greater harmonisation in the interpretation and application of technical guidelines and requirements for product registration in order to reduce or obviate the need to duplicate the testing carried out during the research and development of new medicines. The objective of such harmonisation is a more economical use of human, animal and material resources, and the elimination of unnecessary delay in the global development and availability of new medicines whilst maintaining safeguards on quality, safety and efficacy, and regulatory obligations to protect public health. This Mission is embodied in the Terms of Reference of ICH.
The ICH Secretariat can be contacted on ich@ifpma.org.
<Home> <ICH Structure> <ICH Steering Committee> <ICH Process> <ICH Topics> <ICH Meetings>
<ICH News>
Copyright©1996 International Federation of Pharmaceutical Manufacturers Associations
If you have any comments or suggestions about these web pages
please contact Margaret Cone, Vice President for Scientific Affairs, IFPMA
m.cone@ifpma.org..
PharmWeb is a specialist Internet provider for pharmaceutical and health-related organisatons and is mirrored at sites all over the world. Access to the mirrored sites for these pages is available via the PharmWeb Home page.
PharmWeb - Copyright©1994. All rights reserved.